These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 28393205

  • 1. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
    Tang J, Qin Z, Han P, Wang W, Yang C, Xu Z, Li R, Liu B, Qin C, Wang Z, Tang M, Zhang W.
    Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P, Kang B, Li Y, Hao W, Ma F.
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [Abstract] [Full Text] [Related]

  • 4. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M, Cai L, Wang X, Yu Y, Jian W, Bao G, Gao Z, Guo J, Zhang J, Li C, Zhang C.
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [Abstract] [Full Text] [Related]

  • 5. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY, Tang SJ, Chuang MJ, Cha TL, Li JY, Sun GH, Sun KH.
    Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway.
    Jiang H, Shi QQ, Ge LY, Zhuang QF, Xue D, Xu HY, He XZ.
    Cancer Med; 2019 Aug; 8(10):4836-4844. PubMed ID: 31274247
    [Abstract] [Full Text] [Related]

  • 8. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
    Tang J, Wang F, Cheng G, Si S, Sun X, Han J, Yu H, Zhang W, Lv Q, Wei JF, Yang H.
    J Exp Clin Cancer Res; 2018 Feb 27; 37(1):40. PubMed ID: 29482572
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH, Yang J, Gao LK, Min J, Tang JM, Hu M, Li Y, Li ST, Chen J, Hong L.
    Oncol Rep; 2019 Feb 27; 41(2):917-927. PubMed ID: 30483796
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway.
    Zhang D, Wang S, Chen J, Liu H, Lu J, Jiang H, Huang A, Chen Y.
    Int J Oncol; 2017 May 27; 50(5):1513-1530. PubMed ID: 28339091
    [Abstract] [Full Text] [Related]

  • 14. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J, Wang X, Wen G, Ren Y.
    Oncol Rep; 2019 Nov 27; 42(5):1677-1688. PubMed ID: 31545453
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of ETS2 inhibits the invasion and metastasis of renal cell carcinoma cells by inducing EMT via the PI3K/Akt signaling pathway.
    Zhang GW, Tian X, Li Y, Wang ZQ, Li XD, Zhu CY.
    Biomed Pharmacother; 2018 Aug 27; 104():119-126. PubMed ID: 29772431
    [Abstract] [Full Text] [Related]

  • 16. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X, Cui H, Lou Z, Huang S, Ren Y, Wang P, Weng G.
    Mol Med Rep; 2017 Jun 27; 15(6):4191-4198. PubMed ID: 28487942
    [Abstract] [Full Text] [Related]

  • 17. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J, Xie L, Lv J, Zhang W, Lv J, Liang Y, Geng Y, Li X.
    J Cell Biochem; 2019 Apr 27; 120(4):6709-6717. PubMed ID: 30390334
    [Abstract] [Full Text] [Related]

  • 18. LINC00968 functions as an oncogene in osteosarcoma by activating the PI3K/AKT/mTOR signaling.
    Liu G, Yuan D, Sun P, Liu W, Wu PF, Liu H, Yu GY.
    J Cell Physiol; 2018 Nov 27; 233(11):8639-8647. PubMed ID: 29904919
    [Abstract] [Full Text] [Related]

  • 19. Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling.
    Yang Z, Xie H, He D, Li L.
    Oncotarget; 2016 Jul 12; 7(28):44478-44491. PubMed ID: 27283897
    [Abstract] [Full Text] [Related]

  • 20. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
    Zhu Q, Zhong AL, Hu H, Zhao JJ, Weng DS, Tang Y, Pan QZ, Zhou ZQ, Song MJ, Yang JY, He JY, Liu Y, Li M, Hu WM, Yang CP, Xiang T, Chen MY, Ma G, Guo L, Xia JC.
    J Hematol Oncol; 2020 Jan 03; 13(1):2. PubMed ID: 31900208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.